期刊文献+

可乐定用于戒烟

Clonidine on cigarette withdrawal symptoms
原文传递
导出
摘要 可乐定用于烟龄5a以上愿戒烟者23例,男21例,女2例;年龄46±11a;d1-2服1片(75μg),d3-11服1片bid,d12-13服1片qd,d14-15服0.5片qd,为一个疗程。减轻或消除戒烟症状,包括烟欲、焦虑不安、紧张急躁和精神不集中等。有效率91%,戒断率74%,随访重抽率22%,失败率26%。无效2例,占9%。可乐定可作为戒烟辅助药物。 A total of 23 smokers (M 21, F2, age 46+11 a) who smoked more than 5 a and wished to abandon were given clonidine hydrochloride 75ug qd on d 1-2; 75 ug bid on d 3-11, 75 /u-g qd on d 12-13 and 37.5ug qd on d 14-15. It decreased the withdrawal symptoms, including craving, anxiety, irritability, and difficulty in concentration. There was a 91% response rate, a 74% success rate but a 22% recurring ra.te and a 26% failure rate. The results provide evidence for efficacy of clonidine as an aid to give up smoking.
出处 《新药与临床》 CSCD 北大核心 1992年第6期328-329,共2页
关键词 可乐定 治疗应用 戒烟 clonidine/therapeutic use smoking substance withdrawal syndrome新药与临床 New Drugs and Clinical Remedies 1992年11月 11(6):329
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部